Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Administrative data

Description of key information

The acute oral and dermal toxicity of NX 8000J is low. The LD50 is >2000 mg/kg bw, for both oral and dermal exposure.

Key value for chemical safety assessment

Acute toxicity: via oral route

Endpoint conclusion
Dose descriptor:
LD50
Value:
2 000 mg/kg bw

Acute toxicity: via dermal route

Endpoint conclusion
Dose descriptor:
LD50
Value:
2 000 mg/kg bw

Additional information

In accordance with column 2 of REACH Annex VII, the acute toxicity by inhalation does not need to be determined as exposure of humans via inhalation is unlikely.

The acute oral toxicity was determined in a study according to OECD guideline 425 (up-an-down procedure). In this study female rats were exposed to either 175, 550 or 2000 mg/kg bw NX 8000J. There were no deaths, no clinical signs and no macroscopic abnormalities.

The acute dermal toxicity was determined in a study according to OECD guideline 402 (acute dermal toxicity). In this study male and female rats were exposed to 2000 mg/kg bw NX 8000J. There were no deaths, no clinical signs or signs of irritation and no macroscopic abnormalities.

Justification for classification or non-classification

Based on the LD50of > 2000 mg/kg bw in rats for both oral and dermal expsoure, and the absence of other major significant effects, NX 8000J does not need to be classified for acute toxicity according to EU Directive 67/548/EEC and EU Classification, Labelling and Packaging of Substances and Mixtures (CLP) Regulation (EC) No. 1272/2008.